Intelligent Bio Solutions (INBS) Non Operating Investment Income (2020)
Intelligent Bio Solutions (INBS) recorded quarterly Non Operating Investment Income of -$135692.0 in Q3 2020.
Intelligent Bio Solutions (INBS) Non Operating Investment Income (2020) Analysis & Trends
Intelligent Bio Solutions' Non Operating Investment Income history runs 1 years deep, the most recent figure standing at -$135692.0 for Q3 2020.
- In Q3 2020, Non Operating Investment Income changed N/A year-over-year to -$135692.0; the TTM figure through Jun 2021 stood at -$135692.0 (changed N/A YoY), while the FY2021 annual figure was -$135692.0, down 211.5% from the prior year.
- Non Operating Investment Income was -$135692.0 for Q3 2020 at Intelligent Bio Solutions.
- In the past five years, Non Operating Investment Income ranged from a high of -$135692.0 in Q3 2020 to a low of -$135692.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Op. Investment Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | - |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | - |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | - |
| 10 | Intelligent Bio Solutions | 12.89 Mn | 11.69 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -135,692.00 |
| Sep 30, 2020 | -135,692.00 |